"Designing Growth Strategies is in our DNA"

Platelet Incubator Market Size, Share, and Industry Analysis, By Product Type (Bench-top and Floor-standing), By Type (Single Door and Double Door), By End-user (Blood Banks, Hospitals, Research Labs, and Others), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI110300 | Status : Ongoing

 

KEY MARKET INSIGHTS

A platelet incubator is a medical device designed to store platelet concentrates at a controlled temperature, typically between 20°C and 24°C, to maintain their quality and viability for transfusion. These incubators are used in hospitals, blood banks, and research settings to ensure the optimal storage environment for platelets after their collection. They often come with integrated platelet agitators that move the platelet bags in a controlled manner to prevent sedimentation and maintain the platelets' quality.

The growing incidence of chronic diseases such as cardiovascular disorders and thrombocytopenia (a condition characterized by a low blood platelet count) is expected to fuel market growth in the coming years. These conditions are most often treated with a platelet transfusion, which is driving the utilization of the platelet incubators for the storage of the donor platelets prior to the transfusion.

  • For instance, as per the data published by the National Center for Biotechnology Information (NCBI) in April 2023, there was a twofold increase in cases of immune thrombocytopenia in 2021 as compared to the previous year.
  • Also, as per the article published by the National Center for Biotechnology Information (NCBI) in June 2024, platelet transfusion is mainly preferred for the treatment of thrombocytopenia or platelet function disorders through the prevention of bleeding in patients.

Furthermore, the platelet transfusion process is also carried out in patients with leukemia, aplastic anemia, myelodysplasia, inherited or acquired/medication-induced platelet dysfunction, solid tumors, central nervous system trauma, and patients undergoing cardiopulmonary bypass. These indications together are expected to boost the usage of platelet incubators, driving market growth in the coming years.

Moreover, the advancements in these platelet storage systems, such as the introduction of intelligent controllers that automatically maintain continuity in operations and the emergence of digital temperature recorders for optimal accuracy, are propelling the demand for platelet incubators. This is expected to boost the market growth during the forecast period.

The COVID-19 pandemic had a positive impact on the platelet incubator market. The pandemic led to a surge in the number of platelet transfusions, particularly for COVID-19 patients requiring critical care. This fueled the demand for platelet incubators, driving the market growth in 2020.

  • For instance, as per the data published by the Centers for Disease Control and Prevention in October 2023, despite a decrease in RBC transfusion, apheresis platelet transfusions increased in 2020 as compared to 2019. This increased the use of platelet incubators, propelling the market growth during the pandemic.

Segmentation

By Product Type

By Type

By End-user

By Geography

  • Bench-top
  • Floor-standing
  • Single Door
  • Double Door
  • Blood Banks
  • Hospitals
  • Research Labs
  • Others
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, Australia, India, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (GCC, South Africa, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Incidence of Key Diseases, By Key Countries/Region, 2023
  • Overview: Blood Donation Statistics By Key Countries
  • Overview: Technological Advancements in Platelet Incubators
  • Key Industry Developments (Mergers, Acquisitions, Partnerships)
  • Impact of COVID-19 on the Market

Analysis by Product Type

Based on the product type, the market is categorized into bench-top and floor-standing. The floor-standing segment is projected to account for a significant share of the global platelet incubator market during the forecast period. The floor-standing models are used more frequently due to their higher capacity and flexibility in terms of accommodating the multiple platelet agitators. This allows them to handle larger volumes of platelet storage, making them more suitable for laboratories and blood banks that require efficient and reliable storage solutions. These benefits associated with the floor-standing incubators are expected to boost segmental growth in the coming years.

  • For instance, as of June 2024, QED Scientific states that the bench-top version stores up to 96 x 450ml bags, with one of the floor-standing versions storing up to 340 x 450ml bags and the second up to 680 x 450 ml bags.

On the other hand, the bench-top segment is anticipated to grow at a significant CAGR during the forecast period. The bench-top incubators typically have lower capacities compared to the floor-standing incubators, which makes them more suitable for smaller-scale operations or those with limited space. This is expected to boost the segment growth in the coming years. Furthermore, the rising use of these incubators in the blood banks due to its moderate storage capacity for platelet concentrates, ranging from a few to several units is also projected to boost its demand, driving the segment growth in the forthcoming years.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the platelet incubator market during the forecast period. The market growth of this region is primarily attributed to the significant diagnostic rate of blood-related disorders, including aplastic anemia, in countries such as the U.S. This is driving the need for platelet transfusion procedures in the region, propelling the demand for platelet incubators. In such a case, the regional market is expected to grow significantly during the forecast period.

  • For instance, as of June 2024, the Cleveland Clinic reports that 300 to 900 individuals in the U.S. receive an aplastic anemia diagnosis annually. This is leading to an increase in detection rates of such conditions, thereby fueling the demand for platelet transfusion.

Asia Pacific is expected to grow at a significant CAGR during the forecast period. The growth is attributed to the growing awareness regarding blood-related disorders in the region. The rising diagnoses of these conditions are propelling the demand for these incubators in the region. In addition, the increasing geriatric population in the region is expected to increase the risk of such disorders, fueling the demand for platelet transfusion. These factors are expected to boost the utilization of platelet incubators, driving market growth in the forthcoming years.

Key Players Covered

The market consists of significant players, such as Helmer Scientific Inc., NÜVE SANAYΔ° MALZEMELERΔ° Δ°MALAT VE TΔ°CARET A.Ş. Biolab Scientific, Terumo Corporation, Meditech, BIOBASE BIODUSTY(SHANDONG), Co., Ltd., and Boekel Scientific.

Key Industry Developments

  • In August 2023, Helmer Scientific Inc. announced the launch of the Pro Line Floor Model platelet storage systems to offer optimal platelet storage and support blood bank compliance.
  • In June 2023, Haier Biomedical won the bid for the Chilean blood bank project. Following this bid, its platelet incubator with agitator was installed in the blood bank of San Juan de Dios Hospital in Santiago.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann